Population-based genetic screening technologies exemplify the challenges of translating technical potential into coordinated systems of health service delivery. These technologies offer promise related to diagnosis and/or disease management, but also generate information that is difficult to interpret or not directly health-serving. The role of these screening initiatives in the maternal-child health context is particularly charged. Pregnant women, infants and young children are the recipients of an increasing number of screening services that are complicated by the social and medical intricacies of the decisions on offer. Population-based evaluative research, using a range of methodologies, can inform relevant policy in this area.
Dr. Robin Hayeems completed her doctorate in public health sciences and did her post-doctoral training in health policy research. She is currently completing additional post-doctoral training in health services research at the Institute for Clinical Evaluative Sciences. She has extensive experience with mixed methods, qualitative, public engagement and systematic review methods and is co-investigator on several CIHR-funded projects related to population-based screening programs. She has practical policy development and evaluation experience having lead the development of evidence-informed policy related to newborn screening in the province.
Stay up-to-date on upcoming events and calls for abstracts by visiting our calendar. If you have submissions, or questions or comments about the items above, send them to email@example.com.
Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA). If you require accommodations to participate in this event, please contact 647-260-7100 or firstname.lastname@example.org.